| - Industry | - Sector | Mr. Leonard Liptak CEO | NASDAQ (CM) Exchange | 50535E116 CUSIP |
| US Country | 136 Employees | - Last Dividend | - Last Split | 23 Jul 2021 IPO Date |
ProSomnus, Inc. is a distinguished medical technology company that specializes in the innovation, production, and distribution of precision intraoral devices designed specifically for the treatment and management of obstructive sleep apnea. Based in Pleasanton, California, ProSomnus positions itself as a pioneer in sleep medicine by offering advanced solutions that cater to a diverse range of healthcare professionals. With a strategic focus on sleep dentistry, sleep medicine, primary healthcare, otolaryngology, and integrated healthcare services, ProSomnus leverages a direct sales force to ensure its cutting-edge products are accessible to a broad spectrum of medical providers committed to improving patient outcomes in sleep apnea treatment.
ProSomnus, Inc. has developed a comprehensive portfolio of products and services designed to meet the myriad needs of patients suffering from obstructive sleep apnea and the healthcare providers who treat them. These include: